Franklin Resources’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,377,236
Closed -$32.9M 1601
2019
Q4
$32.9M Buy
1,377,236
+41,646
+3% +$1.15M 0.02% 639
2019
Q3
$35.8M Buy
1,335,590
+200,000
+18% +$5.61M 0.02% 607
2019
Q2
$30.8M Buy
1,135,590
+177,600
+19% +$5.57M 0.02% 657
2019
Q1
$33.2M Sell
957,990
-108,010
-10% -$3.12M 0.02% 619
2018
Q4
$20.8M Buy
1,066,000
+379,300
+55% +$7.8M 0.01% 697
2018
Q3
$18.3M Buy
686,700
+34,900
+5% +$1.14M 0.01% 803
2018
Q2
$24.6M Buy
+651,800
New +$24.9M 0.01% 715
2016
Q3
Sell
-576,318
Closed -$13.6M 1538
2016
Q2
$13.6M Sell
576,318
-739,494
-56% -$18.3M 0.01% 903
2016
Q1
$26.8M Buy
1,315,812
+443,411
+51% +$14.1M 0.01% 730
2015
Q4
$44.9M Sell
872,401
-362,300
-29% -$17.6M 0.02% 581
2015
Q3
$52.6M Sell
1,234,701
-308,200
-20% -$14.9M 0.03% 542
2015
Q2
$70.3M Buy
1,542,901
+44,300
+3% +$1.78M 0.03% 488
2015
Q1
$56.9M Sell
1,498,601
-188,226
-11% -$6.47M 0.03% 560
2014
Q4
$47.8M Sell
1,686,827
-107,974
-6% -$3M 0.02% 609
2014
Q3
$45.4M Buy
1,794,801
+159,100
+10% +$4.19M 0.02% 611
2014
Q2
$47.7M Buy
1,635,701
+566,000
+53% +$13.7M 0.02% 616
2014
Q1
$27.7M Buy
1,069,701
+446,900
+72% +$11.9M 0.01% 771
2013
Q4
$16M Buy
622,801
+93,500
+18% +$2.27M 0.01% 875
2013
Q3
$14.2M Buy
529,301
+57,400
+12% +$1.37M 0.01% 887
2013
Q2
$11.6M Buy
+471,901
New +$9.38M 0.01% 904

Other funds holding PTLA

Franklin Resources's PTLA Position: Q1 2020 in Review

Franklin Resources sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q1 2020, closing a stake of 1,377,236 shares — an estimated $32.9M sold.

Franklin Resources first reported a position in PTLA in Q2 2013 and held it in 20 quarters. The position peaked at $70.3M in Q2 2015. 187 funds tracked by Wall St. Rank hold PTLA as of Q1 2020.

  • Franklin Resources reported no remaining Portola Pharmaceuticals, Inc. position as of Q1 2020 after selling out during the quarter.
  • Franklin Resources sold 1,377,236 Portola Pharmaceuticals, Inc. shares in Q1 2020, an estimated $32.9M.
  • Franklin Resources first reported a position in Portola Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Franklin Resources's Portola Pharmaceuticals, Inc. position peaked at $70.3M in Q2 2015.
  • 187 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q1 2020.

Based on Franklin Resources's 13F filing for Q1 2020, filed 13 May 2020.